| 1783 Stock | | | TWD 44.60 1.15 2.65% |
The current 90-days correlation between Maxigen Biotech and Phytohealth Corp is 0.33 (i.e., Weak diversification). The correlation of Maxigen Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Maxigen Biotech Correlation With Market
Good diversification
The correlation between Maxigen Biotech and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Maxigen Biotech and DJI in the same portfolio, assuming nothing else is changed.
The ability to find closely correlated positions to Maxigen Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Maxigen Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Maxigen Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Maxigen Biotech to buy it.
Moving against Maxigen Stock
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations | | High negative correlations |
Risk-Adjusted IndicatorsThere is a big difference between Maxigen Stock performing well and Maxigen Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Maxigen Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Maxigen Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
| | CEOs DirectoryScreen CEOs from public companies around the world |
Maxigen Biotech Corporate Management
Elected by the shareholders, the Maxigen Biotech's board of directors comprises two types of representatives: Maxigen Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maxigen. The board's role is to monitor Maxigen Biotech's management team and ensure that shareholders' interests are well served. Maxigen Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maxigen Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.